The Mission of University Endoscopy Group is to provide excellent gastrointestinal care in a timely fashion. Personalized, efficient and comprehensive care is provided for a wide array of gastrointestinal and liver diseases, by employing the newest medical technology and the highest clinical standards.
University Endoscopy Group
Business Office Manager: Debra Zaino, CPC
Beginning on 11/6/17
Rhode Island Central Billing Office
1637 Mineral Springs Avenue | Suite 203
North Providence, Rhode Island 02904
Ph: 401.383.0530 | Fax: 401.383.7807
What University Endoscopy Group Offers
The Mission of University Endoscopy Group is to provide excellent diagnostic and therapeutic gastrointestinal care in a timely fashion. Personalized, efficient and comprehensive care is provided for a wide array of gastrointestinal and liver diseases, by employing the newest medical technology and the highest clinical standards.
University Endoscopy Group is very much involved with many clinical studies concerning Hepatitis B and Hepatitis C.
Dr. Thomas Sepe is the lead physician involved with many of these clinical trials, in coordination with other UEG physicians. He and his clinical research team are actively enrolling patients. Many of the trials are cutting edge national studies, providing hope to patients suffering from these illnesses.
Cutting Edge Endoscopy
Many innovative diagnostic and therapeutic modalities are employed by the physicians of University Endoscopy Group. These include Endoscopic Mucosal Resection for early esophageal and gastric malignancies and Cholangioscopy for the diagnosis and treatment of difficult biliary cases.
Newer diagnostic capabilities have been made available by the creative use of Spiral Enteroscopy, developed by Dr. Paul Akerman and his team. He has developed a unique and useful technique to diagnosis and treat small intestinal lesions.
Inflammatory Bowel Disease
Several of our University Endoscopy Group physicians are recognized specialists in the management and diagnosis of Crohn’s Disease and Ulcerative Colitis. Dr. Sheldon Lidofsky has been instrumental in the organization of the OSCCAR (Ocean State Crohn’s & Colitis Area Registry) study, sponsored in conjunction with the National Institute of Health and the IBD Center at Massachusetts General Hospital.
New modalities for the treatment of this disease have been developed. One of the new treatments for Barrett’s Esophagus with dysphasia is the use of radiofrequency ablation (BARRX). This new technology is being used by several physicians at University Endoscopy Group, including Drs. Joseph Pianka, William Chen, and Paul Akerman, making this treatment modality available at our Providence and Newport sites.
University Gastroenterology Network
We at University Endoscopy Group recognize that even our best attempts may require additional consultative assistance. We have established a very close working relationship with the Massachusetts General Hospital in Boston for those patients who may need additional super specialist care.